In8bio Inc Stock Performance

INAB Stock  USD 1.93  0.00  0.00%   
On a scale of 0 to 100, In8bio holds a performance score of 7. The company owns a Beta (Systematic Risk) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, In8bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding In8bio is expected to be smaller as well. Please check In8bio's information ratio, treynor ratio, and the relationship between the downside deviation and total risk alpha , to make a quick decision on whether In8bio's current price history will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in In8bio Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, In8bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:30
Last Split Date
2025-06-06
1
Can IN8bio Inc. stock hit analyst price targets - Buy Signal Weekly Setup with ROI Potential - newser.com
11/11/2025
2
Can IN8bio Inc. stock reach 200 price target - Rate Hike AI Powered Buy and Sell Recommendations - newser.com
11/17/2025
3
Is IN8bio Inc. stock cheap at current valuation - 2025 Key Lessons Daily Volume Surge Trade Alerts - newser.com
11/20/2025
4
IN8bio Inc. Stock Price Live Quotes Charts NASDAQ - StocksToTrade
12/02/2025
5
Street Watch Will IN8bio Inc. stock attract ESG investors - Quarterly Profit Report AI Enhanced Trading Alerts -
12/18/2025
6
Acquisition by Fairbairn Emily of 724637 shares of In8bio at 1.38 subject to Rule 16b-3
12/22/2025
7
Acquisition by Kate Rochlin of 7247 shares of In8bio at 1.38 subject to Rule 16b-3
12/26/2025
8
IN8bio Presents Updated Phase III Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
01/12/2026
9
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
02/03/2026
Begin Period Cash Flow21.5 M
Total Cashflows From Investing Activities-187 K

In8bio Relative Risk vs. Return Landscape

If you would invest  155.00  in In8bio Inc on November 7, 2025 and sell it today you would earn a total of  44.00  from holding In8bio Inc or generate 28.39% return on investment over 90 days. In8bio Inc is currently generating 0.6573% in daily expected returns and assumes 7.192% risk (volatility on return distribution) over the 90 days horizon. In different words, 64% of stocks are less volatile than In8bio, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days In8bio is expected to generate 9.55 times more return on investment than the market. However, the company is 9.55 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

In8bio Target Price Odds to finish over Current Price

The tendency of In8bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.93 90 days 1.93 
about 50.0
Based on a normal probability distribution, the odds of In8bio to move above the current price in 90 days from now is about 50.0 (This In8bio Inc probability density function shows the probability of In8bio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days In8bio has a beta of 0.12. This usually indicates as returns on the market go up, In8bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding In8bio Inc will be expected to be much smaller as well. Additionally In8bio Inc has an alpha of 0.2123, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   In8bio Price Density   
       Price  

Predictive Modules for In8bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as In8bio Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.091.889.07
Details
Intrinsic
Valuation
LowRealHigh
0.234.5211.71
Details
Naive
Forecast
LowNextHigh
0.031.718.91
Details
4 Analysts
Consensus
LowTargetHigh
11.3812.5013.88
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as In8bio. Your research has to be compared to or analyzed against In8bio's peers to derive any actionable benefits. When done correctly, In8bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in In8bio Inc.

In8bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. In8bio is not an exception. The market had few large corrections towards the In8bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold In8bio Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of In8bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.21
β
Beta against Dow Jones0.12
σ
Overall volatility
0.32
Ir
Information ratio 0.02

In8bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of In8bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for In8bio Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
In8bio Inc is way too risky over 90 days horizon
In8bio Inc may become a speculative penny stock
In8bio Inc appears to be risky and price may revert if volatility continues
In8bio Inc has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 0.
In8bio Inc currently holds about 25.74 M in cash with (24.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
In8bio Inc has a frail financial position based on the latest SEC disclosures
Roughly 23.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: IN8bio to Present at Upcoming Investor and Scientific Conferences in February

In8bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of In8bio Stock often depends not only on the future outlook of the current and potential In8bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. In8bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding53.5 M
Cash And Short Term Investments11.1 M

In8bio Fundamentals Growth

In8bio Stock prices reflect investors' perceptions of the future prospects and financial health of In8bio, and In8bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on In8bio Stock performance.

About In8bio Performance

By analyzing In8bio's fundamental ratios, stakeholders can gain valuable insights into In8bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if In8bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if In8bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 51.33  45.62 
Return On Tangible Assets(1.31)(1.37)
Return On Capital Employed(1.53)(1.61)
Return On Assets(1.31)(1.37)
Return On Equity(2.42)(2.30)

Things to note about In8bio Inc performance evaluation

Checking the ongoing alerts about In8bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for In8bio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
In8bio Inc is way too risky over 90 days horizon
In8bio Inc may become a speculative penny stock
In8bio Inc appears to be risky and price may revert if volatility continues
In8bio Inc has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 0.
In8bio Inc currently holds about 25.74 M in cash with (24.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
In8bio Inc has a frail financial position based on the latest SEC disclosures
Roughly 23.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: IN8bio to Present at Upcoming Investor and Scientific Conferences in February
Evaluating In8bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate In8bio's stock performance include:
  • Analyzing In8bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether In8bio's stock is overvalued or undervalued compared to its peers.
  • Examining In8bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating In8bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of In8bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of In8bio's stock. These opinions can provide insight into In8bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating In8bio's stock performance is not an exact science, and many factors can impact In8bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for In8bio Stock analysis

When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities